Recording intelligenceAI-generated brief · check the source for context

CAR T Cells and IL-9 Signaling in Solid Tumors

1:14:43 recording · AUTO · 4 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Cindy Leifer opens Immune 101 with a brand-new Immunity paper from Carl June's lab, first author Sophia Castelli, testing whether adding the native IL-9 receptor to CAR T cells makes them work in solid tumors, which are over 90% of cancers.4:56
  • In a pancreatic ductal adenocarcinoma mouse model, delivering IL-9 locally by adenovirus to tumors treated with IL-9-receptor CAR T cells produced complete remission in 5 out of 10 mice, while CAR T alone, receptor without cytokine, or cytokine alone did nothing.15:22
  • In a human PDAC xenograft, 10 out of 10 mice went into remission and stayed resistant on re-challenge, because the IL-9 signal pushed the cells toward early memory rather than exhaustion and lowered PD-1 and TIM-3.16:52
  • Vincent Racaniello then covers a PNAS paper, first authors Arianna Capuchetti and Giuliana Falivene, showing tattoo ink travels from the foot pad to the popliteal lymph node within 24 hours, is taken up mainly by medullary macrophages, and kills them by necrosis and apoptosis.27:32
  • Tattooing two days or two months before vaccination lowered anti-spike antibody to the Pfizer mRNA vaccine, but the same inks increased IgM and IgG to an inactivated influenza vaccine, an opposite effect the hosts call the paper's most striking result.56:50

Brief overview

Two papers: IL-9 supercharges CAR T cells in solid tumors, and tattoo ink reshapes vaccine responses.

  1. IL-9 receptor keeps CAR T cells out of exhaustionCAR T cells given the native IL-9 receptor expanded more, infiltrated tumors, kept CAR expression and trended toward early memory instead of exhaustion.
  2. Local cytokine delivery limits on-target off-tumor damageInjecting IL-9 by adenovirus into the tumor means the CAR T cells are super-activated at the tumor site and not elsewhere.
  3. Tattoo ink reaches lymph nodes and alters vaccine responsesInk accumulates in draining lymph nodes for months, kills macrophages, and moved antibody responses down for mRNA vaccine and up for inactivated flu vaccine.

Questions this recording answers

10 questions, each answered where it is said
Does a tattoo change the antibody response to an mRNA COVID vaccine?

In mice, yes. All tattooed groups made less antibody against the spike receptor binding domain at 10 days after vaccination, and red and green ink also lowered IgM at seven days. The reduced IgG showed up even in mice tattooed two months earlier.

Answered around 46:56
Did an inactivated influenza vaccine behave the same way as the mRNA one?

No, the opposite. Black and red ink increased IgM at seven days, and the red group increased anti-influenza IgG at 10 days. Among mice tattooed two months before, red raised IgM at seven days and black and red raised IgG at 10 days.

Answered around 56:50
Where does tattoo ink go after it is put into the skin?

Intravital imaging right after tattooing shows ink travelling through the popliteal lymphatic vessels, peaking about 10 minutes after tattooing, then accumulating in the popliteal lymph node about 24 hours post-tattooing. With black and red ink it also reaches the lumbar lymph nodes, spreading farther.

Answered around 33:32
What does tattoo ink do to macrophages?

Macrophages take the ink up and then appear to undergo necrosis: propidium iodide staining increases 12 hours after adding red or black ink, while green ink showed no toxic effect. The inks also induce apoptosis in the first 48 hours after the ink is added.

Answered around 38:26
Does it matter where the tattoo is relative to where you are vaccinated?

When they tattooed one foot pad and immunized the other, contralateral foot pad, there was no effect on antibody responses, at least for mRNA vaccines. So on this data a shoulder tattoo with the shot given in the other arm made no difference.

Answered around 48:28
How well did IL-9 signaling make CAR T cells work in pancreatic tumors?

They got a complete remission in 5 out of 10 mice when CAR T cells carrying the IL-9 receptor were combined with IL-9 delivered into the tumor by an adenovirus vector. CAR T alone, CAR T plus receptor without IL-9, and IL-9 cytokine alone did not work.

Answered around 15:22
What happened with human pancreatic tumor cells rather than the mouse model?

In a xenograft of human PDAC cells in an immunodeficient mouse, 10 out of 10 mice went into remission and killed their tumors, and when re-challenged they were still resistant. These CAR T cells used the endogenous IL-9 receptor responding to the cytokine.

Answered around 16:52
Why do CAR T cells with the IL-9 receptor work better?

In vitro the CAR T cells expanded more and persisted longer, being more resistant to cell death, and in vivo they infiltrated tumors. Their trajectory went toward early memory rather than exhaustion, and they downregulated PD-1 and TIM-3, so inhibitory signals shut them down less.

Answered around 17:58
Why are solid tumors so much harder for CAR T cells than blood cancers?

A solid tumor is a ball of cells that grows and grows, and it is hard for immune cells to get in. If they do get in, they are shut down right away by mechanisms cancer cells use to evade detection. Over 90% of tumors are solid.

Answered around 9:01
How is a CAR T cell made and how does it kill tumor cells?

You take out a patient's T cells and genetically engineer them to express a synthetic receptor: part of an antibody that recognizes something specific on the target cell surface, connected to the hardware needed to activate a T cell. Put back in, they find tumor cells and kill them.

Answered around 7:23
Key Quote

“greater than 90% of tumors are actually solid tumors.”

— Cindy Leifer, CAR T Cells and IL-9 Signaling in Solid Tumors, at 9:38▶ listen at 9:38
Key Quote

“they got a complete remission out of 5 out of 10 of the mice.”

— Cindy Leifer, CAR T Cells and IL-9 Signaling in Solid Tumors, at 15:22▶ listen at 15:22
Key Quote

“However, I always wanted a little virus tattoo on my hand.”

— Vincent Racaniello, CAR T Cells and IL-9 Signaling in Solid Tumors, at 29:39▶ listen at 29:39
Key Quote

“But I think what the big takeaway is, it is so striking that the response to these two vaccines is actually completely opposite.”

— Brianne Barker, CAR T Cells and IL-9 Signaling in Solid Tumors, at 58:40▶ listen at 58:40

Cite this

“CAR T Cells and IL-9 Signaling in Solid Tumors.” https://traffic.libsyn.com/secure/immune/Immune101.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/car-t-cells-and-il-9-signaling-in-solid-tumors.html.

Report this page
What is wrong with this page?